Home

teho Puukottaa piiri kawasaki disease recurrence Kuka akuutti Kohde

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease |  Circulation
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease | Circulation

RACGP - Kawasaki disease – the importance of prompt recognition and early  referral
RACGP - Kawasaki disease – the importance of prompt recognition and early referral

PDF) Recurrent Kawasaki Disease: A Case Report of Three Separate Episodes  at >4-Year Intervals
PDF) Recurrent Kawasaki Disease: A Case Report of Three Separate Episodes at >4-Year Intervals

Frontiers | The Epidemiology and Pathogenesis of Kawasaki Disease |  Pediatrics
Frontiers | The Epidemiology and Pathogenesis of Kawasaki Disease | Pediatrics

Refractory Kawasaki disease: diagnostic and management challenges | PHMT
Refractory Kawasaki disease: diagnostic and management challenges | PHMT

Could SARS-CoV-2 infection revisit the pathogenesis of Kawasaki disease?
Could SARS-CoV-2 infection revisit the pathogenesis of Kawasaki disease?

Paediatric Kawasaki Disease - Clinical Analysis and Cases | Hong Wang |  Springer
Paediatric Kawasaki Disease - Clinical Analysis and Cases | Hong Wang | Springer

Revised recommendations of the Italian Society of Pediatrics about the  general management of Kawasaki disease | Italian Journal of Pediatrics |  Full Text
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text

Defining the risk of first intravenous immunoglobulin unresponsiveness in  non-Asian patients with Kawasaki disease | Scientific Reports
Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease | Scientific Reports

Efficacy of primary treatment with immunoglobulin plus ciclosporin for  prevention of coronary artery abnormalities in patients with Kawasaki  disease predicted to be at increased risk of non-response to intravenous  immunoglobulin (KAICA): a
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a

Frontiers | Kawasaki Disease | Pediatrics
Frontiers | Kawasaki Disease | Pediatrics

Medicina | Free Full-Text | Clinical Manifestations of Kawasaki Disease at  Different Age Spectrum: A Ten-Year Study | HTML
Medicina | Free Full-Text | Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study | HTML

Kawasaki Disease: A Review - Journal of Pediatric Health Care
Kawasaki Disease: A Review - Journal of Pediatric Health Care

Kawasaki Disease Outcomes and Response to Therapy in a Multiethnic  Community: A 10-Year Experience - The Journal of Pediatrics
Kawasaki Disease Outcomes and Response to Therapy in a Multiethnic Community: A 10-Year Experience - The Journal of Pediatrics

Recurrent Kawasaki disease | British Dental Journal
Recurrent Kawasaki disease | British Dental Journal

Recurrence of Kawasaki Disease in a Young Child
Recurrence of Kawasaki Disease in a Young Child

Infliximab for intensification of primary therapy for Kawasaki disease: a  phase 3 randomised, double-blind, placebo-controlled trial - The Lancet
Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial - The Lancet

Frontiers | Increased Incidence of Kawasaki Disease in Taiwan in Recent  Years: A 15 Years Nationwide Population-Based Cohort Study | Pediatrics
Frontiers | Increased Incidence of Kawasaki Disease in Taiwan in Recent Years: A 15 Years Nationwide Population-Based Cohort Study | Pediatrics

Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki  Disease: The Nationwide Survey in Japan, 2017-2018 - The Journal of  Pediatrics
Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki Disease: The Nationwide Survey in Japan, 2017-2018 - The Journal of Pediatrics

Effective infliximab therapy for the early regression of coronary artery  aneurysm in Kawasaki disease - International Journal of Cardiology
Effective infliximab therapy for the early regression of coronary artery aneurysm in Kawasaki disease - International Journal of Cardiology

PDF) Clinical characteristics of hemophagocytic lymphohistiocytosis  following Kawasaki disease: differentiation from recurrent Kawasaki disease
PDF) Clinical characteristics of hemophagocytic lymphohistiocytosis following Kawasaki disease: differentiation from recurrent Kawasaki disease

Cardiac Sequelae in Recurrent Cases of Kawasaki Disease: A Comparison  Between the Initial Episode of the Disease and a Recurrence in the Same  Patients | American Academy of Pediatrics
Cardiac Sequelae in Recurrent Cases of Kawasaki Disease: A Comparison Between the Initial Episode of the Disease and a Recurrence in the Same Patients | American Academy of Pediatrics

Kawasaki disease for dermatologists Gupta A, Singh S - Indian Dermatol  Online J
Kawasaki disease for dermatologists Gupta A, Singh S - Indian Dermatol Online J

A case of recurrent Kawasaki disease - ScienceDirect
A case of recurrent Kawasaki disease - ScienceDirect

While relatively rare, Kawasaki disease can be mistaken for other ailments  and can damage heart if not treated - pennlive.com
While relatively rare, Kawasaki disease can be mistaken for other ailments and can damage heart if not treated - pennlive.com

Recurrent Kawasaki disease and cardiac complications: nationwide surveys in  Japan | Archives of Disease in Childhood
Recurrent Kawasaki disease and cardiac complications: nationwide surveys in Japan | Archives of Disease in Childhood

PDF) Recurrent Kawasaki disease, United States and Japan
PDF) Recurrent Kawasaki disease, United States and Japan

Kawasaki Disease | PedsCases
Kawasaki Disease | PedsCases